PCSK9 inhibitors-Evolocumab (Repatha) etc. vs HMG Co-A RI's-Statins- in hypercholesterolemia (effect on mortality)?

Does anyone have any link to studies on the comparative effectiveness of the PCSK9 inhibitors such as Evolocumab versus the HMG Co-A Reductase Inhibitors (Statins) in the treatment of...

16 January 2018 2,820 3 View